KBL Merger (Unit)

YTD

ALL

Why Robinhood?

You can watch KBLMU and buy or sell other stocks, ETFs, and their options commission-free!

About KBLMU

180 Life Sciences Corp. operates as a clinical-stage biotechnology company, which engages in the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain by leveraging the combined expertise of luminaries in therapeutics from Oxford University, the Hebrew University and Stanford University. The company was founded by Marc Feldmann, Lawrence J.

CEO

Blair Jordan, MBA

CEOBlair Jordan, MBA

Employees

Employees3

Headquarters

Palo Alto, California

HeadquartersPalo Alto, California

Founded

2016

Founded2016

Employees

Employees3

KBLMU Key Statistics

Market cap

26.62M

Market cap26.62M

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

348.40

Average volume348.40

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$14.52

52 Week high$14.52

52 Week low

$7.62

52 Week low$7.62